Peer-reviewedCC BYCureus
Ischemic Colitis in the Setting of Tirzepatide Use: A Potentially Underrecognized Adverse Effect
- 1Family Medicine, Broward Health Medical Center, Fort Lauderdale, USA
- 2Family Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA
Related
- Minor Myeloid Leukemic Populations in Pediatric Acute Lymphoblastic Leukemia: A Potentially Underrecognized Mixed-Phenotype Tumor?
- Fulminant Ischemic Colitis With Toxic Megacolon in a Young Man Receiving Testosterone Replacement Therapy Despite Therapeutic Phlebotomy for Hereditary Hemochromatosis: A Case Report
- Diabetic Retinal Disease Onset and Progression During Established Semaglutide or Tirzepatide Treatment: A Retrospective Comparative Cohort Study With a Descriptive Regional Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Review.
- Kayexalate-Induced Ischemic Colitis: Revisiting a Forgotten but Preventable Cause of Colonic Necrosis.
- Atypical Multisegmental Involvement in Suspected Ischemic Colitis: A Case Report
BibTeX
@article{jaszewski2026ischemic,
title = {{Ischemic Colitis in the Setting of Tirzepatide Use: A Potentially Underrecognized Adverse Effect}},
author = {Isabel Jaszewski and Jean C Cruz Garcia and Karina Moreira and Ana E Suarez and Rebecca Cherner},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702369},
note = {CC BY},
}
RIS
TY - JOUR
TI - Ischemic Colitis in the Setting of Tirzepatide Use: A Potentially Underrecognized Adverse Effect
AU - Isabel Jaszewski
AU - Jean C Cruz Garcia
AU - Karina Moreira
AU - Ana E Suarez
AU - Rebecca Cherner
PY - 2026
DA - 2026/10/27
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13702369
SN - 2168-8184
ER -